Company Profile

CHO Pharma, founded in 2013, is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. Together with our strategic partner, Academia Sinica in Taiwan, we strive for continuous innovation on glycan-based technology and are committed to deliver best-in-class targeted and differentiated products. Our goal is to bring advanced, high-quality and affordable medicines, diagnostics and therapies to patients around the world.

Fulfill our vision through sharing, co-creation and pursuing excellence.
CHO Pharma is dedicated to address unmet medical needs and to deliver solutions valuable to patients through its innovative glycan engineering technologies and platforms, and brand Taiwan biotechnology in the global arena.
As a research-oriented company committed to innovation, CHO Pharma's missions are to become a global leading biopharmaceutical company specialized on glycan-based technology, to keep sustainable growth and develop products that are beneficial to patients worldwide.